This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Milk’s words challenge us to speak up—not only for LGBTQ+ rights, but also for compassionate, equitable healthcare that includes access to plant medicine. Whether we’re advocating for end-of-life dignity, cannabinoid therapies, or affirming care for queer youth, hope becomes activism when it is shared aloud. References Awareness Days.
Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. We are excited to explore the potential of emergent psychedelic therapies. ABOUT SANTÉ CANNABIS. Caution Regarding Forward-Looking Information.
Activists in Mississippi have already collected thousands of signatures in hopes of qualifying a medical cannabis ballot initiative for the 2020 ballot. Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed. CT resident? CT resident? FL resident?
But it’s acknowledged that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. The university has conducted research that studied the best music to include in psychedelic therapy. What is Psychedelic Therapy.
The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.
Of the card-holding patients, more than 83,000 purchased products from a dispensary, and more than 600,000 transactions were collectively reported by the licensed dispensaries. Pennsylvania state lawmakers like Sen. “In Costa wrote on Twitter. Clearly, this was a serious need in the Commonwealth.”.
Activists in Nebraska, along with two pro-legalization Senators, qualified a 2020 medical cannabis ballot initiative petition to begin collecting signatures from registered voters in the state. House Bill 19-1028 would permit physicians to recommend cannabis therapy to those diagnosed with an autism spectrum disorder. CO resident?
That’s just one step being taken to prepare the state for the eventual implementation of Measure 109, in which 56 percent of voters approved last fall to legalize psychedelic mushroom therapy. . The post This New BIPOC-Run Group Is Educating People About Legal Mushroom Therapy in Oregon appeared first on SpeedWeed.
Veriheal does not support illegally consuming alternative therapeutic substances but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting psychedelic therapy. A Magical Future.
is a pioneering Psychedelic Healthcare Innovation & Life Sciences Company in early stage development of Psilocybin (“Magic Mushroom”) based drugs and therapies proudly announces t he Filing of U. HENDERSON, Nev. , Sept. 9, 2021 /PRNewswire/ — PsiloThera, Inc.
The diversified venture fund is focused on tackling the growing global mental health crisis by investing in innovative psychedelic-based and adjacent therapies that are poised to shape the future of psychiatry and fields beyond. Innovative psychedelic-based and adjacent therapies are poised to shape the future of psychiatry and fields beyond.
Dedicated to “redefining what’s possible,” the 501(c)(3) organization has provided 1:1 support and resources to over 69,000 clients as they navigated plant-powered cannabinoid therapy. RoC also works to increase patients’ access to medical cannabis by helping U.S.
The study found that 58% of physicians agree that “medical cannabis was a legitimate medical therapy.” ” The study concludes: “Providers generally believe that medical cannabis is a legitimate medical therapy. Healthcare providers play a critical role in facilitating patient access to medical cannabis.
Activists collected over 100,000 more signatures than needed to qualify the measure for the ballot, showing significant support for its passing. In a statement to The Denver Post, Natural Medicine Colorado—which sponsored the act—said “the measure is designed to prioritize mental health and healing, while balancing safety and access.”
Current statistics from the Anthenum Collective show that more than 67% of Americans believe cannabis should be legal, and legal cannabis sales are expected to achieve a value of $73.6 States that have legal access to medical and recreational cannabis often work with state-regulated insurers to obtain limited property and liability coverage.
Researchers say this emphasizes just how important it is that psilocybin therapy be done in a controlled setting with therapy and community-based after-care. The 14-page document covers several aspects of the drug development process, including trial best practices, data collection, and new drug application requirements.
These products have not been shown to be safe or effective, and deceptive marketing of unproven treatments may keep some patients from accessing appropriate, recognized therapies to treat serious and even fatal diseases.”. Specifically, the agency fears that.
ADCL’s solution includes the use of subcontractor CLEARED4’s health verification platform for appointments, sample tracking, and value-add services of campus access management. As prime contractor, ADCL will also provide on-site staffing and sample transport and logistics.
The Contract contains no minimum testing requirement; it stipulates a fixed monthly fee for sample collection site services and a separate fixed fee per individual COVID-19 test. The initial Contract term is one year and includes two one-year options for renewal exercisable at the College’s discretion.
1647, the Veterans Equal Access Act, which expands medical cannabis access to eligible military veterans. Legislation is pending, HB 33 / SB 893, to permit physicians to recommend cannabis therapy to those struggling with opioid abuse or dependence. Welcome to the latest edition of NORML’s Weekly Legislative Roundup!
This direct access to patients and clinics is expected to differentiate KGK from other CROs by providing the opportunity to study patients with differing demographics across various populations, while also shortening recruitment timelines for studies. The recent addition of KGK Science Inc. On behalf of: KETAMINE ONE.
The TGA has approved the use of MDMA and Psilocybin to treat mental illness in Australia by qualified medical professionals under a special access scheme. The results of this survey cannot be shared with you, as the survey does not collect any contact details or personal information. Here’s the details on the research project.
So while a cannabis business can join their local chamber of commerce, a patient in hospice can be denied access to medical cannabis. Those who access cannabis through the hemp market or own businesses in hemp are not protected either, as loose definitions of hemp that can be altered in the next Farm Bill reauthorization.
million to assess the efficacy of Multidisciplinary Association for Psychedelic Studies (MAPS) MDMA-assisted therapy to treat traumatic brain injury (TBI). Wesana is a serious, thoughtful and ethical company engaged in the development of psychedelic-assisted therapy. Lately, MAPS research zeroed in on MDMA-assisted therapy for PTSD.
Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. a global leader in the cannabis industry serving both medical and consumer markets and dedicated to helping people improve their lives. .
Global Psychiatry Partnering 2014 to 2021 provides the full collection of Psychiatry disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Access to headline, upfront, milestone and royalty data. Access to hundreds of Psychiatry deal contract documents. Specific therapy indication.
According to a recent report released by the Psychedelic Science Funders Collaborative, “Oregon’s psilocybin therapy program provides a high-quality model for psychedelic healing in a non-prescription context that could be replicated in other states.”
tonnes of cannabis that will be collected in the span of four years, with an annual harvest of 2.6 The company was founded in 2013 to provide patients, medical institutions, doctors, and pharmacists across Europe with access to safe and reliable cannabis-based medicine. euros per gram. The Federal Agency asked for a volume of 10.4
The acceptance of medical cannabis by clinicians, researchers and government bodies is fairly universal, and patients have benefited from widespread access to full-spectrum cannabis in flower and oil form. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.
include Beboe, Dogwalkers, Dr. Solomon’s, Incredibles, Rhythm, and The Feel Collection. This company’s market capitalization is $9.278 billion and is responsible for manufacturing and distributing cannabis in the medical and recreational markets. The cannabis brands from Green Thumb Industries Inc. Canopy Growth Corporation.
Silo Wellness is a publicly traded company on the CSE with a consumer-facing platform for the sale of functional mushroom products, psilocybin mushroom production in Jamaica, and the facilitation of psychedelic wellness retreats in both Jamaica and Oregon that incorporate a variety of psychedelic-augmented therapies. ir@silowellness.com.
The use of psychedelic substances to treat mental illness and physical disorders is known as “psychedelic therapy.” In a typical scenario, psychedelic substances would be used in conjunction with psychotherapy sessions to treat disorders for which other medicinal therapies have failed. Psychedelic therapy is not a fringe phenomenon.
The talks will be made public, open-access on YouTube two weeks after the event. Dr. Stanislav Grof and Brigitte Grof – Stan Grof is the world’s leading researcher in psychedelic therapy, breathwork, and the exploration of non-ordinary states of consciousness, with wife and psychotherapist, Brigitte. Saturday, June 26, 2021.
This collectively brings the Company’s total clinic count to 15 globally. Khiron in the United Kingdom The company is pursuing a consistent approach to improve patient access to medical cannabis and to develop the market for medical cannabis treatments in the UK.
As a collective enterprise, Ketamine One is dedicated to helping solve the growing need for safe and accessible mental health therapy. The recent addition of KGK Science Inc. On behalf of: KETAMINE ONE. ” Adam Deffett ” Adam Deffett, Interim CEO.
The deal also provides the group with the ability to build upon MTL’s current brand portfolio, and develop a diverse flower menu bringing premium, accessible products to cannabis consumers while maintaining existing supply agreements. Enhanced retail sales portfolio through immediate access to brands distributed in Québec; and.
This list is available by request to those seeking access to psilocybin through the Special Access Program (SAP), and clinical researchers. These doses are produced under Good Agricultural and Collection Practices and tested for potency and impurities to support patient safety and practitioner confidence. investment community.”
As psychedelic medicine becomes more mainstream, we must ensure that all who participate in healing therapeutic sessions, both above ground and in ceremonial or underground therapeutic settings, are safe and accessible to all. Emma teaches classes on integrating kink-based consent practices into psychedelic-assisted therapy.
To prepare for your appointment you will want to collect your medical records about the condition you wish to treat with medical cannabis. A medical provider may recommend medical cannabis to treat any condition that they feel may benefit from medical cannabis and cannabinoid-based therapies.
Now, he is the Vice-Chair of Indiana NORML — an organization who is currently focused on changing cannabis laws for the access to Medical Cannabis as therapeutic treatment in Indiana. Providing patients safe access to therapeutic marijuana/cannabis. Straw is a retired USAF Critical Care Air Transport nurse who has served in combat.
Common treatments for chronic pain can include: Pharmaceuticals (painkillers, anti-inflammatories) Physical therapy Lifestyle changes (exercise, diet) Despite medical advancements, many patients find these methods still don’t offer adequate relief. This is where medical marijuana becomes a viable option. and proof of residency.
The watchdog said a network of children’s doctors should be created to collect evidence and advice on difficult cases. The guidance said for people with MS, Sativex can be an effective treatment when the individual which has not responded to other therapies, however it does not recommend it due to the costs involved.
Cannabis is still very much illegal in many countries, which makes it very challenging for researchers to gain access to materials, money, and opportunities to conduct research in the first place. Studies with greater sample sizes and better data collection are sorely needed.
Approved patients will have access to over 80 dispensaries throughout the state and may purchase up to a 30 day supply at a time. To prepare for your appointment you will want to collect your medical records pertaining to the qualifying condition you wish to treat with Medical Cannabis.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content